Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) lacks effective treatment options beyond chemotherapy. Although molecular subtypes such as classical and QM (quasi-mesenchymal)/basal-like with transcriptome-based distinct signatures have been identified, deduced therapeutic strategies and targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Heid, Irina, Münch, Corinna, Karakaya, Sinan, Lueong, Smiths S., Winkelkotte, Alina M., Liffers, Sven T., Godfrey, Laura, Cheung, Phyllis F. Y., Savvatakis, Konstantinos, Topping, Geoffrey J., Englert, Florian, Kritzner, Lukas, Grashei, Martin, Tannapfel, Andrea, Viebahn, Richard, Wolters, Heiner, Uhl, Waldemar, Vangala, Deepak, Smeets, Esther M. M., Aarntzen, Erik H. J. G., Rauh, Daniel, Weichert, Wilko, Hoheisel, Jörg D., Hahn, Stephan A., Schilling, Franz, Braren, Rickmer, Trajkovic-Arsic, Marija, Siveke, Jens T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737747/
https://www.ncbi.nlm.nih.gov/pubmed/36494842
http://dx.doi.org/10.1186/s40170-022-00298-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737747/
https://www.ncbi.nlm.nih.gov/pubmed/36494842
http://dx.doi.org/10.1186/s40170-022-00298-5

Ejemplares similares